Cefepime-induced neurotoxicity: systematic review.
Maan G, Keitoku K, Kimura N, Sawada H, Pham A, Yeo J, Hagiya H, Nishimura Y.
J Antimicrob Chemother. 2022 Oct 28;77(11):2908-2921. doi: 10.1093/jac/dkac271.
WARS2 Deficiency.
Mroczek M, Busra A, Houlden H, Efthymiou S, Nagy S.
2023 Oct 12. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
Status epilepticus in Hashimoto's encephalopathy.
Ercoli T, Defazio G, Muroni A.
Seizure. 2019 Aug;70:1-5. doi: 10.1016/j.seizure.2019.06.020. Epub 2019 Jun 13.
Update on the management of status epilepticus.
Rossetti AO, Alvarez V.
Curr Opin Neurol. 2021 Apr 1;34(2):172-181. doi: 10.1097/WCO.0000000000000899.
Perampanel in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus.
Strzelczyk A, Willems LM, Willig S, Rosenow F, Bauer S.
Expert Rev Clin Pharmacol. 2015;8(6):733-40. doi: 10.1586/17512433.2015.1091303. Epub 2015 Oct 5.
Epileptic encephalopathy.
Dulac O.
Epilepsia. 2001;42 Suppl 3:23-6. doi: 10.1046/j.1528-1157.2001.042suppl.3023.x.
Brivaracetam in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus.
Strzelczyk A, Klein KM, Willems LM, Rosenow F, Bauer S.
Expert Rev Clin Pharmacol. 2016;9(5):637-45. doi: 10.1586/17512433.2016.1156529. Epub 2016 Mar 7.
Atypical Rasmussen's encephalitis presenting as focal status epilepticus and periodic generalised myoclonus.
Rudrabhatla PK, Mehnaz F, Metta S.
Acta Neurol Belg. 2023 Dec;123(6):2431-2433. doi: 10.1007/s13760-023-02267-1. Epub 2023 Apr 10.
Ceftazidime-related nonconvulsive status epilepticus.
Klion AD, Kallsen J, Cowl CT, Nauseef WM.
Arch Intern Med. 1994 Mar 14;154(5):586-9.
Benign neonatal sleep myoclonus mimicking status epilepticus.
Turanli G, Senbil N, Altunbaşak S, Topçu M.
J Child Neurol. 2004 Jan;19(1):62-3. doi: 10.1177/08830738040190010708.
